Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Lantheus Holdings, Inc. (LNTH) vs Liquidia Corporation (LQDA)

Lantheus Holdings, Inc. and Liquidia Corporation are both Drug Manufacturers Specialty & Generic companies. Lantheus Holdings, Inc. and Liquidia Corporation are of similar size ($6.5B and $6.4B). Lantheus Holdings, Inc. trades at the lower P/E: 23.7× against 43.6×. Liquidia Corporation grew revenue faster over the last twelve months: 2,233.7% against 2.35%. Liquidia Corporation has the higher net margin (30.7% vs 17.7%) and the higher return on invested capital (121.1% vs 14.7%). Across the 21 metrics below, Liquidia Corporation leads on 11 and Lantheus Holdings, Inc. on 10.

Valuation

Metric LNTH LQDA Drug Manufacturers Specialty & Generic median
P/E 23.69 43.59 20.14
P/S 4.18 13.49 2.25
P/B 4.95 31.17 1.90
Price to free cash flow 16.54 40.36 16.54
EV/EBITDA 16.38 35.09 12.29
EV/Sales 4.16 13.25 2.56
Earnings yield 4.22% 2.29% (2.99%)
Free cash flow yield 6.04% 2.48% 0.00%

Profitability

Metric LNTH LQDA Drug Manufacturers Specialty & Generic median
Gross margin 60.14% 92.54% 53.94%
Operating margin 19.43% 37.39% 0.00%
Net margin 17.69% 30.74% 0.00%
Free cash flow margin 25.24% 33.42% 0.00%
Return on equity 22.21% 131.82% (0.40%)
Return on assets 12.15% 35.57% (3.32%)
Return on invested capital 14.65% 121.05% 0.00%

Growth

Metric LNTH LQDA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 2.35% 2,233.65% 10.01%
EPS growth (last fiscal year) (21.79%) 51.81% —
Revenue growth, 5-year CAGR 35.35% 65.24% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LNTH LQDA Drug Manufacturers Specialty & Generic median
Debt to equity 0.44 0.90 0.05
Current ratio 3.06 2.31 2.31
Net debt to EBITDA 0.55 (0.01) 0.85

Dividend

Metric LNTH LQDA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric LNTH LQDA Drug Manufacturers Specialty & Generic median
Market cap 6.51b 6.36b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack